Medexus Pharmaceuticals Inc. ( MEDXF) - Key Metrics
MEDXF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0.88 | $0.02 | -$0.04 | -$0.04 |
| 2026Q4 | $0.77 | -$0.08 | $0.12 | -$0.35 |
| 2026Q3 | $0.78 | $0 | $0.24 | $0.24 |
| 2026Q2 | $0.77 | -$0.01 | $0.10 | $0.10 |
| 2026Q1 | $0.76 | $0.02 | $0.12 | $0.12 |
MEDXF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | 53.59 |
| 2026Q4 | 0% | -6.80 |
| 2026Q3 | 0% | 211.00 |
| 2026Q2 | 0% | -49.22 |
| 2026Q1 | 0% | 36.11 |
MEDXF
Price: $3.39
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -114.50
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 105.7 million